Clinical Study of Spectral CT Verida
ConditionVolunteers
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorPhilips Clinical & Medical Affairs Global
About this trial
This study will prospective enroll 80 subjects to evaluate the comparison of image quality, proportion of high-quality images, and image noise between the Spectral Precise Image (SPI) intelligent denoising for low-dose scans on the Spectral CT Verida system and iDose4 reconstructions after low-dose and routine-dose scans.
Eligibility criteria
Qualifiers
18 ≤ age ≤ 75 years.
18 kg/m² ≤ BMI ≤ 28 kg/m².
Conscious, able to cooperate, and competent to perform study procedures. Voluntarily agrees to participate in this clinical study and has signed the informed consent form.
Women of childbearing potential must have a negative pregnancy test and have no plans to become pregnant during the next 6 months.
Disqualifiers
Persons without full civil capacity.
Pregnant or breastfeeding women.
Any other conditions that, in the investigator's judgment, make the subject unsuitable for participation in this clinical study.
Trial design
Treatments tested in this trial
- CT Radiation Scan
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Philips Clinical & Medical Affairs Global
Lead sponsor
Qilu Hospital of Shandong University
Collaborator
Source ClinicalTrials.gov